Maternal CD4+ cell count decline after interruption of antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIV.
<h4>Background</h4>We evaluated maternal CD4+ cell count (CD4+) decline after PMTCT prophylaxis in a multi-country HIV care program.<h4>Methods</h4>Analysis was restricted to antiretroviral therapy (ART)-naive, HIV-infected pregnant women with CD4+ ≥250 cells/mm(3) at enrollm...
Guardado en:
Autores principales: | Didier Ekouevi, Elaine J Abrams, Malka Schlesinger, Landon Myer, Nittaya Phanuphak, Rosalind J Carter, MTCT-Plus Initiative |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9fcdfef59cf4646a4bda60603e0c5c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq G, et al.
Publicado: (2018) -
Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS)
por: Landon Myer, et al.
Publicado: (2021) -
Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.
por: Matilda Ngarina, et al.
Publicado: (2014) -
Fitness Cost of Antiretroviral Drug Resistance Mutations on the <i>pol</i> Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: James R. Hunter, et al.
Publicado: (2021) -
Why do patients interrupt and return to antiretroviral therapy? Retention in HIV care from the patient's perspective in Johannesburg, South Africa.
por: Melanie A Bisnauth, et al.
Publicado: (2021)